| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.37B | 127.47B | 180.74B | 250.57B | 223.38B | 184.55B |
| Gross Profit | 18.19B | 20.41B | 30.58B | 53.04B | 56.54B | 54.03B |
| EBITDA | 10.84B | 12.14B | 20.24B | 41.42B | 40.65B | 41.88B |
| Net Income | 7.75B | 10.40B | 12.85B | 24.36B | 23.85B | 20.00B |
Balance Sheet | ||||||
| Total Assets | 631.60B | 665.64B | 700.41B | 786.77B | 875.65B | 765.16B |
| Cash, Cash Equivalents and Short-Term Investments | 42.63B | 38.40B | 59.23B | 72.13B | 88.19B | 77.45B |
| Total Debt | 198.49B | 206.69B | 207.48B | 224.77B | 228.48B | 196.65B |
| Total Liabilities | 387.16B | 420.16B | 463.95B | 553.60B | 653.77B | 572.43B |
| Stockholders Equity | 165.07B | 161.43B | 151.97B | 142.10B | 124.95B | 108.34B |
Cash Flow | ||||||
| Free Cash Flow | 35.41B | 29.41B | 32.16B | 9.66B | 28.00B | 35.86B |
| Operating Cash Flow | 35.62B | 29.75B | 33.01B | 9.96B | 28.53B | 36.73B |
| Investing Cash Flow | -9.26B | -11.60B | -11.61B | -12.41B | -48.73B | -41.40B |
| Financing Cash Flow | -32.64B | -29.42B | -34.27B | -13.56B | 31.30B | 20.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$396.71B | 6.70 | 3.55% | 3.89% | 4.66% | 26.27% | |
66 Neutral | HK$229.62B | 3.64 | 8.80% | 5.18% | 2.11% | -0.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$56.57B | 52.44 | 0.65% | 3.96% | -23.93% | -89.99% | |
54 Neutral | HK$135.50B | 7.48 | 3.54% | 4.54% | -9.39% | -19.08% | |
44 Neutral | HK$48.18B | -0.40 | -52.03% | ― | -31.93% | -79.74% | |
39 Underperform | HK$12.23B | 3.16 | -3.01% | ― | -38.67% | ― |